Strategies to target pancreatic cancer

Geou Yarh Liou, Peter Storz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreatic cancer has the highest mortality rate among all major types of solid cancers. Due to early metastasis to other organs, late detection and high resistance to chemotherapy, only 5-6% of pancreatic cancer patients will survive more than 5 years after diagnosis. Critical issues for increasing patient survival are (1) to develop new methods for early detection of tumor development or cancer cell dissemination, and (2) to develop new treatment strategies that target chemoresistance and the desmoplastic reaction and make tumor cells accessible to conventional chemotherapy. In this chapter, we discuss genetic alterations that can lead to the development of pancreatic cancer, possibilities for early detection of pancreatic cancer, as well as strategies targeting signaling pathways involved in mediating resistance to chemotherapy.

Original languageEnglish (US)
Title of host publicationMolecular Targets and Strategies in Cancer Prevention
PublisherSpringer International Publishing
Pages1-20
Number of pages20
ISBN (Electronic)9783319312545
ISBN (Print)9783319312521
DOIs
StatePublished - Jan 1 2016

Fingerprint

Chemotherapy
Pancreatic Neoplasms
Tumors
Cells
Drug Therapy
Neoplasms
Early Detection of Cancer
Neoplasm Metastasis
Survival
Mortality
Therapeutics

Keywords

  • Chemotherapy resistance
  • Early detection
  • Kras mutations
  • Pancreatic cancer
  • Treatment

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Liou, G. Y., & Storz, P. (2016). Strategies to target pancreatic cancer. In Molecular Targets and Strategies in Cancer Prevention (pp. 1-20). Springer International Publishing. https://doi.org/10.1007/978-3-319-31254-5_1

Strategies to target pancreatic cancer. / Liou, Geou Yarh; Storz, Peter.

Molecular Targets and Strategies in Cancer Prevention. Springer International Publishing, 2016. p. 1-20.

Research output: Chapter in Book/Report/Conference proceedingChapter

Liou, GY & Storz, P 2016, Strategies to target pancreatic cancer. in Molecular Targets and Strategies in Cancer Prevention. Springer International Publishing, pp. 1-20. https://doi.org/10.1007/978-3-319-31254-5_1
Liou GY, Storz P. Strategies to target pancreatic cancer. In Molecular Targets and Strategies in Cancer Prevention. Springer International Publishing. 2016. p. 1-20 https://doi.org/10.1007/978-3-319-31254-5_1
Liou, Geou Yarh ; Storz, Peter. / Strategies to target pancreatic cancer. Molecular Targets and Strategies in Cancer Prevention. Springer International Publishing, 2016. pp. 1-20
@inbook{f549e1c0c28248eeb582b2e85f4edf6e,
title = "Strategies to target pancreatic cancer",
abstract = "Pancreatic cancer has the highest mortality rate among all major types of solid cancers. Due to early metastasis to other organs, late detection and high resistance to chemotherapy, only 5-6{\%} of pancreatic cancer patients will survive more than 5 years after diagnosis. Critical issues for increasing patient survival are (1) to develop new methods for early detection of tumor development or cancer cell dissemination, and (2) to develop new treatment strategies that target chemoresistance and the desmoplastic reaction and make tumor cells accessible to conventional chemotherapy. In this chapter, we discuss genetic alterations that can lead to the development of pancreatic cancer, possibilities for early detection of pancreatic cancer, as well as strategies targeting signaling pathways involved in mediating resistance to chemotherapy.",
keywords = "Chemotherapy resistance, Early detection, Kras mutations, Pancreatic cancer, Treatment",
author = "Liou, {Geou Yarh} and Peter Storz",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-31254-5_1",
language = "English (US)",
isbn = "9783319312521",
pages = "1--20",
booktitle = "Molecular Targets and Strategies in Cancer Prevention",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Strategies to target pancreatic cancer

AU - Liou, Geou Yarh

AU - Storz, Peter

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Pancreatic cancer has the highest mortality rate among all major types of solid cancers. Due to early metastasis to other organs, late detection and high resistance to chemotherapy, only 5-6% of pancreatic cancer patients will survive more than 5 years after diagnosis. Critical issues for increasing patient survival are (1) to develop new methods for early detection of tumor development or cancer cell dissemination, and (2) to develop new treatment strategies that target chemoresistance and the desmoplastic reaction and make tumor cells accessible to conventional chemotherapy. In this chapter, we discuss genetic alterations that can lead to the development of pancreatic cancer, possibilities for early detection of pancreatic cancer, as well as strategies targeting signaling pathways involved in mediating resistance to chemotherapy.

AB - Pancreatic cancer has the highest mortality rate among all major types of solid cancers. Due to early metastasis to other organs, late detection and high resistance to chemotherapy, only 5-6% of pancreatic cancer patients will survive more than 5 years after diagnosis. Critical issues for increasing patient survival are (1) to develop new methods for early detection of tumor development or cancer cell dissemination, and (2) to develop new treatment strategies that target chemoresistance and the desmoplastic reaction and make tumor cells accessible to conventional chemotherapy. In this chapter, we discuss genetic alterations that can lead to the development of pancreatic cancer, possibilities for early detection of pancreatic cancer, as well as strategies targeting signaling pathways involved in mediating resistance to chemotherapy.

KW - Chemotherapy resistance

KW - Early detection

KW - Kras mutations

KW - Pancreatic cancer

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85068820328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068820328&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-31254-5_1

DO - 10.1007/978-3-319-31254-5_1

M3 - Chapter

SN - 9783319312521

SP - 1

EP - 20

BT - Molecular Targets and Strategies in Cancer Prevention

PB - Springer International Publishing

ER -